helmholtzeyeinstituteРоссийский офтальмологический журналRussian Ophthalmological Journal2072-00762587-5760Real time Publishers10.21516/2072-0076-2020-13-4-105-110helmholtzeyeinstitute-528Research ArticleОБЗОРЫ ЛИТЕРАТУРЫREVIEWSПрогностические факторы функциональных результатов хирургии идиопатических (первичных) эпимакулярных мембран: кистозный макулярный отек. Часть 2Prognostic factors of functional results of surgery for idiopathic (primary) epimacular membranes: cystoid macular edema. Part 2ТоропыгинС. Г.ToropyginS. G.

Сергей Григорьевич Торопыгин — д-р мед. наук, доцент, заведующий кафедрой офтальмологии

ул. Советская, д. 4, Тверь, 170100

Sergei G. Toropygin — Dr. of Med. Sci., assistant professor, head of chair of ophthalmology

4, Sovetskaya St., Tver, 170100

doctorop@mail.ruНазароваС. Г.NazarovaS. V.

Станислава Вячеславна Назарова — аспирант кафедры офтальмологии

ул. Советская, д. 4, Тверь, 170100

Stanislava V. Nazarova — postgraduate student, chair of ophthalmology

4, Sovetskaya St., Tver, 170100

stanislava.n@list.ruДаварахХ.DawarahH.

Хаиян Даварах — врач-офтальмолог

ул. Советская, д. 4, Тверь, 170100

Haijan Dawarah — ophthalmologist, chair of ophthalmology

4, Sovetskaya St., Tver, 170100

МасловА. Н.MaslovA. N.

Александр Николаевич Маслов — ассистент кафедры физики, математики и медицинской информатики

ул. Советская, д. 4, Тверь, 170100

Alexander N. Maslov — assistant professor, the chair of physics, mathematics and medical informatics

4, Sovetskaya St., Tver, 170100

ФГБОУ ВО «Тверской ГМУ» Минздрава РоссииРоссияTver State Medical UniversityRussian Federation202017122020134105110Copyright © Торопыгин С.Г., Назарова С.Г., Даварах Х., Маслов А.Н., 20202020Торопыгин С.Г., Назарова С.Г., Даварах Х., Маслов А.Н.Toropygin S.G., Nazarova S.V., Dawarah H., Maslov A.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://roj.igb.ru/jour/article/view/528

Во второй части обзора (первую часть см. РОЖ 2020; 13 (2): 99–104) рассматриваются динамика резорбции кистозного макулярного отека (КМО), изменения макулярного профиля после удаления идиопатических эпимакулярных мембран (ЭММ), влияние КМО и макулярного профиля на состояние зрительных функций при ЭММ, а также вопросы лечения КМО после их удаления.

The second part of the review (for the first part, see ROJ 2020; 13 (2): 99–104), discusses the dynamics of cystoid macular edema (CME) resorption, macular profile changes after the removal of idiopathic epimacular membranes (EMM), the impact of CME and the macular profile on visual functions of eyes with EMM, and issues of CME management after EMM removal.

эпимакулярная мембранакистозный макулярный отекоптическая когерентная томографиявитреоретинальная хирургияepimacular membranecystoid macular edemaoptical coherence tomographyvitreoretinal surgeryReferencesMaguire A.M., Margherio R.P., Dmuchowski C. Preoperative fluorescein angiographic features of surgically removed idiopathic epiretinal membrane. Retina. 1994; 14 (5): 411–6. doi:10.1097/00006982-199414050-00004Maguire A.M., Margherio R.P., Dmuchowski C. Preoperative fluorescein angiographic features of surgically removed idiopathic epiretinal membrane. Retina. 1994; 14 (5): 411–6. doi:10.1097/00006982-199414050-00004Charles S., Calzada J., Wood B. Vitreous microsurgery. Lippincott Williams and Wilkins; 2007.Charles S., Calzada J., Wood B. Vitreous microsurgery. Lippincott Williams and Wilkins; 2007.Ducournau D., Ducournau Y., Kuhn F. Surgery for idiopathic epiretinal membrane and macular edema. A new concept based on a personal experience of over 16000 cases. Multimedia interactive book. 2011.Ducournau D., Ducournau Y., Kuhn F. Surgery for idiopathic epiretinal membrane and macular edema. A new concept based on a personal experience of over 16000 cases. Multimedia interactive book. 2011.Wickham L., Gregor Z. Epiretinal membranes. 5th ed. Los Angeles: 2013; 1954–61. doi.org/10.1016/B978-1-4557-0737-9.00116-8Wickham L., Gregor Z. Epiretinal membranes. 5th ed. Los Angeles: 2013; 1954–61. doi.org/10.1016/B978-1-4557-0737-9.00116-8Торопыгин С.Г. Хирургия тонких интраокулярных структур. Тверь: ИП Орлова З.П.; 2014.Toropygin S.G. Surgery of thin intraocular structures. Tver: IP Orlova Z.P; 2014 (in Russian).Shahidi M., Ogura Y., Blair N.P., et al. Retinal thickness analysis for quantitative assessment of diabetic macular edema. Arch. Ophthalmol. 1991; 109: 1115–9. doi:10.1136/bjo.78.11.827Shahidi M., Ogura Y., Blair N.P., et al. Retinal thickness analysis for quantitative assessment of diabetic macular edema. Arch. Ophthalmol. 1991; 109: 1115–9. doi:10.1136/bjo.78.11.827Frisina R., Pinackatt S.J., Sartore M., et al. Cystoid macular edema after pars plana vitrectomy for idiopathic epiretinal membrane. Graefes Arch. Clin. Exp. Ophthalmol. 2015; 253 (1): 47–56. doi:10.1007/s00417-014-2655-xFrisina R., Pinackatt S.J., Sartore M., et al. Cystoid macular edema after pars plana vitrectomy for idiopathic epiretinal membrane. Graefes Arch. Clin. Exp. Ophthalmol. 2015; 253 (1): 47–56. doi:10.1007/s00417-014-2655-xКоэн С.И., Квинтель Г. Флюоресцентная ангиография в диагностике патологии глазного дна. Пер. с английского. Москва: Рейтар; 2005.Koen S.I., Kvintel' G. Fluorescence angiography in diagnostics of fundus pathology. Тranslation from English. Moscow: Rejtar; 2005 (in Russian).Лумбросо Б., Рисполи М. ОКТ (сетчатка, сосудистая оболочка, глаукома). Пер. c английского. Москва: БИНОМ; 2014.Lumbroso B., Rispoli M. OCT (retina, choroid, glaucoma). Тranslation from English. Mosсow: BINOM; 2014 (in Russian).Fiho C.A., Yehoshua Z., Gregori G., Puliafito C.A., Rosenfeld P.J. Optical coherence tomography. In: Retina Fifth Edition. 2012; 1: 82–110. Elsevier Inc. https://doi.org/10.1016/B978-1-4557-0737-9.00003-5Fiho C.A., Yehoshua Z., Gregori G., Puliafito C.A., Rosenfeld P.J. Optical coherence tomography. In: Retina Fifth Edition. 2012; 1: 82–110. Elsevier Inc. https://doi.org/10.1016/B978-1-4557-0737-9.00003-5Chan A., Duker J.S., Ko T.H., et al. Normal macular thickness measurements in healthy eyes using Stratus optical coherence tomography. Arch. Ophthalmol. 2006; 124: 193–8. doi:10.1001/Farchopht.124.2.193Chan A., Duker J.S., Ko T.H., et al. Normal macular thickness measurements in healthy eyes using Stratus optical coherence tomography. Arch. Ophthalmol. 2006; 124: 193–8. doi:10.1001/Farchopht.124.2.193Kim J., Rhee K.M., Woo S.J., et al. Long-term temporal changes of macular thickness and visual outcome after vitrectomy for idiopathic epiretinal membrane. Am. J. Ophthalmol. 2010; 150(5): 701–9. doi: 10.1016/j.ajo.2010.05.037Kim J., Rhee K.M., Woo S.J., et al. Long-term temporal changes of macular thickness and visual outcome after vitrectomy for idiopathic epiretinal membrane. Am. J. Ophthalmol. 2010; 150(5): 701–9. doi: 10.1016/j.ajo.2010.05.037Mayer W.J., Vogel M., Neubauer A., et al. Pars plana vitrectomy and internal limiting membrane peeling in epimacular membranes: correlation of function and morphology across the macula. Ophthalmologica. 2013; 230: 9–17. doi:10.1159/000350233Mayer W.J., Vogel M., Neubauer A., et al. Pars plana vitrectomy and internal limiting membrane peeling in epimacular membranes: correlation of function and morphology across the macula. Ophthalmologica. 2013; 230: 9–17. doi:10.1159/000350233Massin P., Allouch C., Haouchine B., et al. Optical coherence tomography of idiopathic macular epiretinal membranes before and after surgery. Am. J. Ophthalmol. 2000; 130(6): 732–9. doi:10.1016/S0002-9394(00)00574-2Massin P., Allouch C., Haouchine B., et al. Optical coherence tomography of idiopathic macular epiretinal membranes before and after surgery. Am. J. Ophthalmol. 2000; 130(6): 732–9. doi:10.1016/S0002-9394(00)00574-2Mitamura Y., Mitamura-Aizawa S., Katome T., et al. Photoreceptor impairment and restoration on optical coherence tomographic images. J. Ophthalmol. 2013. Article ID 518170. http://dx.doi.org/10.1155/2013/518170Mitamura Y., Mitamura-Aizawa S., Katome T., et al. Photoreceptor impairment and restoration on optical coherence tomographic images. J. Ophthalmol. 2013. Article ID 518170. http://dx.doi.org/10.1155/2013/518170Niwa T., Terasaki H., Kondo M., et al. Function and morphology of macula before and after removal of idiopathic epiretinal membrane. Invest. Ophthalmol. Vis. Sci. 2003; 44(4): 1652–6. doi:10.1167/iovs.02-0404Niwa T., Terasaki H., Kondo M., et al. Function and morphology of macula before and after removal of idiopathic epiretinal membrane. Invest. Ophthalmol. Vis. Sci. 2003; 44(4): 1652–6. doi:10.1167/iovs.02-0404Shimozono M., Oishi A., Hata M., et al. The significance of cone outer segment tips as a prognostic factor in epiretinal membrane surgery. Am. J. Ophthalmol. 2012; 153 (4): 698–704. doi:10.1016/j.ajo.2011.09.011Shimozono M., Oishi A., Hata M., et al. The significance of cone outer segment tips as a prognostic factor in epiretinal membrane surgery. Am. J. Ophthalmol. 2012; 153 (4): 698–704. doi:10.1016/j.ajo.2011.09.011Suh M.H., Seo J.M., Park K.H., Yu H.G. Associations between macular findings by optical coherence tomography and visual outcomes after epiretinal membrane removal. Am. J. Ophthalmol. 2009; 147(3): 473–80. doi:10.1016/j.ajo.2008.09.020Suh M.H., Seo J.M., Park K.H., Yu H.G. Associations between macular findings by optical coherence tomography and visual outcomes after epiretinal membrane removal. Am. J. Ophthalmol. 2009; 147(3): 473–80. doi:10.1016/j.ajo.2008.09.020Wilkins J.R., Puliafito C.A., Hee M.R., et al. Characterization of epiretinal membranes using optical coherence tomography. Ophthalmology. 1996; 103 (12): 2142–51. doi:10.1016/S0161-6420(96)30377-1Wilkins J.R., Puliafito C.A., Hee M.R., et al. Characterization of epiretinal membranes using optical coherence tomography. Ophthalmology. 1996; 103 (12): 2142–51. doi:10.1016/S0161-6420(96)30377-1Cho K.H., Park S.J., Cho J.H., et al. Inner-retinal irregularity index predicts postoperative visual prognosis in idiopathic epiretinal membrane. Am. J. Ophthalmol. 2016; 168: 139–49. doi:10.1016/j.ajo.2016.05.011Cho K.H., Park S.J., Cho J.H., et al. Inner-retinal irregularity index predicts postoperative visual prognosis in idiopathic epiretinal membrane. Am. J. Ophthalmol. 2016; 168: 139–49. doi:10.1016/j.ajo.2016.05.011Mitamura Y., Hirano K., Baba T., Yamamoto S. Correlation of visual recovery with presence of photoreceptor inner/outer segment junction in optical coherence images after epiretinal membrane surgery. Br. J. Ophthalmol. 2009; 93(2): 171–5. doi: 10.1136/bjo.2008.146381Mitamura Y., Hirano K., Baba T., Yamamoto S. Correlation of visual recovery with presence of photoreceptor inner/outer segment junction in optical coherence images after epiretinal membrane surgery. Br. J. Ophthalmol. 2009; 93(2): 171–5. doi: 10.1136/bjo.2008.146381Bowling B. Kanski's clinical ophthalmology: a systematic approach, 8th edition. Sydney, Australia: Elsevier; 2016.Bowling B. Kanski's clinical ophthalmology: a systematic approach, 8th edition. Sydney, Australia: Elsevier; 2016.Gass J.D.M. Stereoscopic atlas of macular diseases. Diagnosis and treatment, ed. 3. St. Louis: C.V. Mosby; 1987.Gass J.D.M. Stereoscopic atlas of macular diseases. Diagnosis and treatment, ed. 3. St. Louis: C.V. Mosby; 1987.Wells J.A. The paradigm shifts in the management of retinal vein occlusion. Retinal Physician. 2011; Nov. 36–40. https://www.retinalphysician.com/issues/2011/nov-dec/the-paradigm-shifts-in-the-management-of-retinal-vWells J.A. The paradigm shifts in the management of retinal vein occlusion. Retinal Physician. 2011; Nov. 36–40. https://www.retinalphysician.com/issues/2011/nov-dec/the-paradigm-shifts-in-the-management-of-retinal-vLeopold I.H. Nonsteroidal and steroidal anti-inflammatory agents. In: Sears M.L., Tarkkanen A., eds. Surgical pharmacology of the eye. New York: Raven Press; 1985: 83–133.Leopold I.H. Nonsteroidal and steroidal anti-inflammatory agents. In: Sears M.L., Tarkkanen A., eds. Surgical pharmacology of the eye. New York: Raven Press; 1985: 83–133.Hattenbach L.O., Springer-Wanner C., Hoerauf H., et al. Intravitreal sustainedrelease steroid implants for the treatment of macular edema following surgical removal of epiretinal membranes. Ophthalmologica. 2017; 237 (4): 232–7. doi: 10.1159/000464259Hattenbach L.O., Springer-Wanner C., Hoerauf H., et al. Intravitreal sustainedrelease steroid implants for the treatment of macular edema following surgical removal of epiretinal membranes. Ophthalmologica. 2017; 237 (4): 232–7. doi: 10.1159/000464259Sella R., Galor O., Goh Y.W., et al. Role of concomitant triamcinolone acetonide injection in small-gauge vitrectomy for idiopathic epiretinal membrane peel. Asia Pas. J. Ophthalmol. (Phila). 2015; 4 (4): 204–7. doi: 10.1097/APO.0000000000000049Sella R., Galor O., Goh Y.W., et al. Role of concomitant triamcinolone acetonide injection in small-gauge vitrectomy for idiopathic epiretinal membrane peel. Asia Pas. J. Ophthalmol. (Phila). 2015; 4 (4): 204–7. doi: 10.1097/APO.0000000000000049Ahn J.H., Park H.J., Lee J.E., Oum B.S. Effect of intravitreal triamcinolone injection during vitrectomy for idiopathic epiretinal membrane. Retina. 2012; 32 (5): 892–6. doi: 10.1097/IAE.0b013e318229b1f7Ahn J.H., Park H.J., Lee J.E., Oum B.S. Effect of intravitreal triamcinolone injection during vitrectomy for idiopathic epiretinal membrane. Retina. 2012; 32 (5): 892–6. doi: 10.1097/IAE.0b013e318229b1f7Lai C.C., Wang N.K., Wu W.C., et al. The long-term anatomical and visual effect of intravitreal triamcinolone injection during vitrectomy for the treatment of idiopathic macular epiretinal membrane. Cutan. Ocul. Toxicol. 2011; 30 (4): 292–7. doi: 10.3109/15569527.2011.568031Lai C.C., Wang N.K., Wu W.C., et al. The long-term anatomical and visual effect of intravitreal triamcinolone injection during vitrectomy for the treatment of idiopathic macular epiretinal membrane. Cutan. Ocul. Toxicol. 2011; 30 (4): 292–7. doi: 10.3109/15569527.2011.568031Taney L.S., Baumal C.R., Duker J.S. Sustained-release dexamethasone intravitreal implant for persistent macular edema after vitrectomy for epiretinal membrane. Ophthalmic Surg. Lasers Imaging Retina. 2015; 46 (2): 224–8. doi: 10.3928/23258160-20150213-01Taney L.S., Baumal C.R., Duker J.S. Sustained-release dexamethasone intravitreal implant for persistent macular edema after vitrectomy for epiretinal membrane. Ophthalmic Surg. Lasers Imaging Retina. 2015; 46 (2): 224–8. doi: 10.3928/23258160-20150213-01Chen C.H., Wu P.C., Liu Y.C. Intravitreal bevacizumab injection therapy for persistent macular edema after idiopathic macular epiretinal membrane surgery. J. Ocul. Pharmacol. Ther. 2011; 27 (3): 287–92. doi: 10.1089/jop.2010.0166Chen C.H., Wu P.C., Liu Y.C. Intravitreal bevacizumab injection therapy for persistent macular edema after idiopathic macular epiretinal membrane surgery. J. Ocul. Pharmacol. Ther. 2011; 27 (3): 287–92. doi: 10.1089/jop.2010.0166Li Z., Zhang G., Su K., et al. Membrane peeling combined with intravitreal injection of bevacizumab for treatment of macular epiretinal membrane: analysis of 33 cases. Nan. Fang. 2014 Jul; 34 (8): 1207–9. PMID:25176098Li Z., Zhang G., Su K., et al. Membrane peeling combined with intravitreal injection of bevacizumab for treatment of macular epiretinal membrane: analysis of 33 cases. Nan. Fang. 2014 Jul; 34 (8): 1207–9. PMID:25176098Lee S.S., Ghosn C., Yu Z., et al. Vitreous VEGF clearance is increased after vitrectomy. Invest. Ophthalmol. Vis. Sci. 2010; 51 (4): 2135–8. doi: 10.1167/iovs.09-3582Lee S.S., Ghosn C., Yu Z., et al. Vitreous VEGF clearance is increased after vitrectomy. Invest. Ophthalmol. Vis. Sci. 2010; 51 (4): 2135–8. doi: 10.1167/iovs.09-3582Aras C., Arici C., Acar S., et al. Peeling of internal limiting membrane during vitrectomy for complicated retinal detachment prevents epimacular membrane formation. Graefes Arch. Clin. Exp. Ophthalmol. 2009; 247 (5): 619–23. doi:10.1007/s00417-008-1025-yAras C., Arici C., Acar S., et al. Peeling of internal limiting membrane during vitrectomy for complicated retinal detachment prevents epimacular membrane formation. Graefes Arch. Clin. Exp. Ophthalmol. 2009; 247 (5): 619–23. doi:10.1007/s00417-008-1025-yKhokhar A.R., Rab K.F., Akhtar H.U. Management of macular pucker. J. Coll. Physicians Surg. Pak. 2003; 13 (12): 701–3. doi: 12.2003/JCPSP.701703Khokhar A.R., Rab K.F., Akhtar H.U. Management of macular pucker. J. Coll. Physicians Surg. Pak. 2003; 13 (12): 701–3. doi: 12.2003/JCPSP.701703Park D.W., Dugel P.U., Garda J., et al. Macular pucker removal with and without internal limiting membrane peeling: pilot study. Ophthalmology. 2003; 110 (1): 62–4. doi:10.1016/S0161-6420(02)01440-9Park D.W., Dugel P.U., Garda J., et al. Macular pucker removal with and without internal limiting membrane peeling: pilot study. Ophthalmology. 2003; 110 (1): 62–4. doi:10.1016/S0161-6420(02)01440-9Chang-Lin J.E., Burke J.A., Peng Q., et al. Pharmacokinetics of a sustained-release dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyes. Invest. Ophthalmol. Vis. Sci. 2011; 52 (7): 4605–9. doi: 10.1167/iovs.10-6387Chang-Lin J.E., Burke J.A., Peng Q., et al. Pharmacokinetics of a sustained-release dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyes. Invest. Ophthalmol. Vis. Sci. 2011; 52 (7): 4605–9. doi: 10.1167/iovs.10-6387

The authors declare that there are no conflicts of interest present.